Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"... Ampio Pharmaceuticals, Inc. develops innovative proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs, some of which are now starting clinical trials, and new molecular entities ("NMEs"). A key strategy includes actively exploring partnership, licensing and other collaboration opportunities to maximize the company's product development programs. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.0021 | 0.0021 | 0.0021 | 227 | 0.0021 | CS |
| 4 | -0.03845 | -94.8212083847 | 0.04055 | 0.04055 | 0.0006 | 401 | 0.00197878 | CS |
| 12 | -0.0005 | -19.2307692308 | 0.0026 | 0.0861 | 0.0005 | 1444 | 0.00367822 | CS |
| 26 | 0.0001 | 5 | 0.002 | 0.0861 | 0.0004 | 1660 | 0.00426784 | CS |
| 52 | -0.1479 | -98.6 | 0.15 | 0.56 | 1.0E-6 | 3811 | 0.18269999 | CS |
| 156 | -2.7479 | -99.9236363636 | 2.75 | 2.75 | 1.0E-6 | 668775 | 0.02429857 | CS |
| 260 | -0.0034 | -61.8181818182 | 0.0055 | 2.75 | 1.0E-6 | 654237 | 0.02429857 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
